Chemical dependency treatment: the integration of the alcoholism and drug addiction/use treatment systems. NLM AIDSLINE Important note: Information in this article was accurate in 1992. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Chemical dependency treatment: the integration of the alcoholism and drug addiction/use treatment systems.

Int J Addict. 1990-91;25(12A):1515-36. Unique Identifier : AIDSLINE MED/92155847
Rawson RA; Matrix Institute on Addictions, Beverly Hills, CA 90211.

Abstract: The development of the alcoholism and drug addiction/use treatment systems was completely separate. By 1980, the drug addiction/use field had a solid scientific base but was losing momentum as a public priority. The alcoholism treatment system was gaining acceptance and the 28-day hospital was becoming the treatment standard. During the 1980s the cocaine epidemic, the AIDS crisis, and major health care financing shifts brought new currents of change into the system. By the end of the decade, the alcoholism system and drug addiction/use system were extremely out of sync. To maximize the information that each field has to offer the other and to coordinate the treatment effort, a single chemical dependency treatment system is proposed. This development would require the integration of the NIAAA and NIDA. The result would promote the establishment of coordinated treatment standards and subsequent improvement of treatment based upon empirical decision making.
Keywords: Acquired Immunodeficiency Syndrome/PREVENTION & CONTROL/ TRANSMISSION Alcoholism/PSYCHOLOGY/*REHABILITATION Cocaine Combined Modality Therapy Cost-Benefit Analysis Health Services Needs and Demand/ECONOMICS/TRENDS Human Substance Abuse Treatment Centers/ECONOMICS/TRENDS Substance Dependence/PSYCHOLOGY/*REHABILITATION JOURNAL ARTICLE REVIEW REVIEW, TUTORIAL

KWDacquiredimmunodeficiencysyndrome/prevention&control/transmissionalcoholism/psychology/KWDrehabilitationcocainecombinedmodalitytherapycost-benefitanalysishealthservicesneedsanddemand/economics/trendshumansubstanceabusetreatmentcenters/economics/trendssubstancedependence/psychology/KWDrehabilitationjournalarticlereviewreview,tutorial
920530
M9250935

Copyright © 1992 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1992. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1992. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .